ODE Deputy Directors To Manage FDAMA & PDUFA II Responsibilities
Executive Summary
Oncology Drug Products Division Deputy Director Robert Justice is serving as acting division director, following the departure of Robert DeLap, MD/PhD, to become Office of Drug Evaluation V deputy director.
You may also be interested in...
FDA GI Division Director Justice Is Returning To FDA From Genentech
Genentech Senior Clinical Scientist Robert Justice, MD, is returning to FDA as director of the Division of Gastrointestinal & Coagulation Drug Products in September
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011